Publications by authors named "Mark Sarno"

Claim this Profile
V
Validation of Keratin 17 as a tissue biomarker in the diagnosis of upper tract urothelial carcinoma.
Woodson Smelser, Nam Kim, Sholeh Jahanfard, Mark Sarno, Sam S Chang

Hum Pathol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a Multianalyte 'Rule-Out' Assay in Pregnant Individuals With Suspected Preeclampsia.
Maged M Costantine, Baha Sibai, Allan T Bombard, Mark Sarno, Holly West

Hypertension· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.
Sheldon R Morris, Claire C Bristow, Michael R Wierzbicki, Mark Sarno, Lenore Asbel

Lancet Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance for changes in allergic asthma domain variables after short-term corticosteroid therapy.
Philip E Silkoff, Mark Sarno, Solomon Ssenyange, Vivek Balasubramanyam, Brian Awabdy

BMC Pulm Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical precision, accuracy, number and durations of exhalations for a novel electrochemical monitor for exhaled nitric oxide.
Philip E Silkoff, Brian Awabdy, Mark Sarno, Solomon Ssenyange, Vivek Balsubramanyam

J Breath Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel centrifugal technology for measuring sperm concentration in the home.
Ulrich Y Schaff, Laura L Fredriksen, Jon G Epperson, Tiffany R Quebral, Sara Naab, Mark J Sarno

Fertil Steril· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NADiA ProsVue prostate-specific antigen slope, CAPRA-S, and prostate cancer--specific survival after radical prostatectomy.
Judd W Moul, Mark J Sarno, Jonathan E McDermed, Melissa T Triebell, Mark A Reynolds

Urology· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reflex PCA3 messenger ribonucleic acid testing: validation of postbiopsy urine samples and correlation with prostate biopsy findings in ∼2000 patients.
Jeffrey G Brown, John R Fulmer, Javier Romano, John Pownell, Wayne Rigler, Mark Sarno

Urology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.
Judd W Moul, Hans Lilja, O John Semmes, Raymond S Lance, Robert L Vessella, Mark J Sarno

Urology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robustness of ProsVue linear slope for prognostic identification of patients at reduced risk for prostate cancer recurrence: Simulation studies on effects of analytical imprecision and sampling time variation.
Mark J Sarno, Charles S Davis

Clin Biochem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
Jonathan E McDermed, Ron Sanders, Stephen Fait, Robert E Klem, Mark J Sarno

Clin Chem· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer gene 3 score predicts prostate biopsy outcome in men receiving dutasteride for prevention of prostate cancer: results from the REDUCE trial.
Sheila M J Aubin, Jennifer Reid, Mark J Sarno, Amy Blase, Jacqueline Aussie

Urology· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial.
Sheila M J Aubin, Jennifer Reid, Mark J Sarno, Amy Blase, Jacqueline Aussie

J Urol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.
Lori J Sokoll, William Ellis, Paul Lange, Jennifer Noteboom, Debra J Elliott, Mark Sarno

Clin Chim Acta· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study.
Lori B Daniels, Gail A Laughlin, Mark J Sarno, Ricki Bettencourt, Robert L Wolfert

J Am Coll Cardiol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Iris Simon, Dionyssios Katsaros, Irene Rigault de la Longrais, Marco Massobrio, Andreas Scorilas, Mark J Sarno

Gynecol Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer.
Iris Simon, Shaoqiu Zhuo, Laura Corral, Eleftherios P Diamandis, Mark J Sarno

Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.
William Nowatzke, Mark J Sarno, Nathan C Birch, Douglas F Stickle, Tanya Eden

Clin Chim Acta· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.
Janet B McGill, Thomas G Cole, William Nowatzke, Shannon Houghton, Erika B Ammirati, Mark J Sarno

Diabetes Care· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and glucodynamics of rapid-, short-, and intermediate-acting insulins: comparison of jet injection to needle syringe.
Mark J Sarno, Jo Bell, Steven V Edelman

Diabetes Technol Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicology and toxicokinetics of acute and subchronic administration of histamine dihydrochloride in rats.
Linda Karavodin, Rodney Jensen, Mark Sarno, Kurt Gehlsen

Drug Chem Toxicol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2.
Mark Middleton, Mark Sarno, Sanjiv S Agarwala, John Glaspy, Aziz Laurent

J Clin Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine pharmacokinetics in tumor and host tissues after bolus-dose administration in the rat.
Magnus Rizell, Peter Naredi, Per Lindnér, Kristoffer Hellstrand, Mark Sarno

Life Sci· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis